StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Hydrochloric Acid → (6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

HRID 616522
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 616522
[OH:1][CH2:2][C:3]1[CH2:4][S:5][C@@H:6]2[C@H:13]([NH:14][C:15](=[O:25])[C:16](=[N:22][O:23][CH3:24])[C:17]3[O:18][CH:19]=[CH:20][CH:21]=3)[C:12](=[O:26])[N:7]2[C:8]=1[C:9]([OH:11])=[O:10].P([O-])([O-])([O:29][C:30](=O)[NH2:31])=O.P(OC[C@H]1O[C@@H](N2C3N=CN=C(N)C=3N=C2)[C@H](O)[C@@H]1O)(OP(OP(O)(O)=O)(O)=O)(=O)O.[Cl-].[Mg+2].[Cl-].[OH-].[K+].Cl>[Cl-].[Mn+2].[Cl-].C(O)(=O)C>[C:30]([O:1][CH2:2][C:3]1[CH2:4][S:5][C@@H:6]2[C@H:13]([NH:14][C:15](=[O:25])[C:16](=[N:22][O:23][CH3:24])[C:17]3[O:18][CH:19]=[CH:20][CH:21]=3)[C:12](=[O:26])[N:7]2[C:8]=1[C:9]([OH:11])=[O:10])(=[O:29])[NH2:31]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

9

Edukt 6

HCID 313Hydrochloric AcidHCID 59575'-AtpHCID 14797Potassium HydroxideHCID 3423467Carbamic acid, monoanhydride with phosphoric acid, ion(2-)HCID 5360315Magnesium ChlorideHCID 54170549(6R,7R)-3-Hydroxymethyl-7-[2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylic acid

Produkt 1

HCID 41375(6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 10313134Manganese(2+) dichlorideKatalysatorHCID 176Acetic AcidLösungsmittel

Versuchsvorschrift

Concentrated enzyme (0.5 ml) was incubated at 28° in a final volume of 1.0 ml water containing (6R,7R)-3-hydroxymethyl-7-[2-methoxyimino-2-(fur-2-yl) acetamido]-ceph-3-em-4-carboxylic acid (syn-isomer) (0.1 μmole), carbamoyl phosphate (3 μmoles), ATP (1 μmole), magnesium chloride (1 μmole), manganese chloride (1 μmole) & pipes buffer (50 μmoles) adjusted to pH 6.0 with potassium hydroxide. After 2 hr the reaction was stopped by the addition of acetic acid (20 μl). The pH was then adjusted to 2.0 with M hydrochloric acid and the precipitated protein was centrifuged off. The supernatant was extracted with ethylacetate (2.5 ml). The organic phase was collected and evaporated to dryness. The cephalosporins it contained were then separated by hplc [100 mm × 5 mm diam. column Partisil 5 eluted at 1500 psi with chloroform:methanol: 90% formic acid (25:2:1 v/v) saturated with water] and were detected by their absorption at 270 nm. Their retention time was compared with standard samples. The size of the U.V. absorbing peaks showed that 20% of the cephalosporin starting material had been converted to title compound.

Aufarbeitung

  1. concentrationConcentrated enzyme (0.5 ml)
  2. customwas incubated at 28°
  3. extractionThe supernatant was extracted with ethylacetate (2.5 ml)
  4. customThe organic phase was collected
  5. customevaporated to dryness
  6. customThe cephalosporins it contained were then separated by hplc [100 mm × 5 mm diam. column Partisil 5 eluted at 1500 psi with chloroform:methanol: 90% formic acid (25:2:1 v/v) saturated with water]
  7. customwere detected by their absorption at 270 nm

Quellen und Nachweise

ORD-Eintrag
ord-5205b90a00a74d7db9dec97102f859d9
Quelldatensatz
uspto-grants-1978_02
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US04075061

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion